Full Value Beef
The full value of a true partnership
You’ve told us that doing business today is different and we’ve been listening. With low cattle inventories, less forage availability and more market volatility, it’s clear your business is as challenging as ever. We also understand that, to really help you address these challenges, we need to do business differently. This approach — this partnership — is called Full Value Beef.
Full Value Beef is about building partnerships with you, our customer. It starts with identifying your needs and together discovering opportunities that impact your operation’s profitability.
Many of our customers are already applying the value of their Elanco partnerships to help meet their needs and face their biggest challenges. Others are just getting started, learning more about how Elanco’s capabilities match up to their commitments and concerns and how this can have a significant impact on their operation. The foundation of Full Value Beef is built upon these four drivers:
Identify, quantify and reduce the total impact of disease and parasites
Optimize nutritional programs to maximize returns
Maximize saleable output
Build assurance in your products marketed to consumers; enable access to markets and technologies
Elanco products address a variety of animal health and performance issues. Click on the logo below to learn more about each product’s specific applications.
Micotil (tilmicosin injection) is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni, and for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica.
Important safety information
Micotil (tilmicosin injection)
See label for complete use information. Before using this product, it is important to read the entire product insert, including the boxed human warning.
- Caution: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian
- Not for human use. Injection of this drug in humans has been associated with fatalities. Keep out of reach of children. Do not use in automatically powered syringes. Exercise extreme caution to avoid accidental self-injection. In case of human injection, consult a physician immediately and apply ice or cold pack to injection site while avoiding direct contact with the skin. Avoid contact with eyes.
- Always use proper drug handling procedures to avoid accidental self-injection. Consult your veterinarian on the safe handling and use of all injectable products prior to administration.
- For use in cattle or sheep only. Inject subcutaneously. Injection of this antibiotic has been shown to be fatal in swine and non-human primates, and may be fatal in horses and goats.
- Do not use in female dairy cattle 20 months of age or older. Use in lactating dairy cattle or sheep may cause milk residues.
- The following adverse reactions have been reported: in cattle: injection site swelling and inflammation, lameness, collapse, anaphylaxis/anaphylactoid reactions, decreased food and water consumption, and death.
- Micotil has a pre-slaughter withdrawal time of 42 days.
- CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
- Cattle intended for human consumption must not be slaughtered within 28 days of the last treatment.
- To assure both food safety and responsible use, treatment must be initiated within the first 45 days of the production period. The treatment should not occur concurrent with or following administration of an injectable macrolide, or within 3 days following administration of a non-macrolide injectable BRD therapy.
- VFD expiration date must not exceed 45 days from the time of issuance. VFDs shall not be refilled.
- Use only in cattle fed in confinement for slaughter.
- Cattle with severe clinical illness should be evaluated for individual treatment with an alternative non-macrolide therapy.
- Do not use in female dairy cattle 20 months of age or older or in veal calves.
- Safety has not been established for cattle intended for breeding.
- Do not allow horses or other equines access to feeds containing tilmicosin.
- Avoid inhalation, oral exposure and direct contact with skin or eyes. Keep out of reach of children.
- Not for human use. Keep out of reach of children.
- Cattle intended for human consumption must not be slaughtered within 21 days of the last use of this drug product.
- Do not use in dairy cattle 20 months of age or older, including dry dairy cows or in calves intended to be processed for veal.
- Do not administer to horses or other equines. Injection of tylosin in equines has been fatal.
For all products: The labels contain complete use information, including cautions and warnings. Always read, understand and follow the labels and use directions.
For Rumensin: Consumption by unapproved species or feeding undiluted may be toxic or fatal. Do not feed to veal calves.
Rumensin: Growing cattle on pasture or in drylot (stockers, feeders, and dairy and beef replacement heifers)
For increased rate of weight gain: Feed 50 to 200 mg/hd/d of monensin in at least 1.0lb of Type C medicated feed. Or, after the 5th day, feed 400 mg/hd/d every other day in at least 2.0lbs of Type C medicated feed. The Type C medicated feed must contain 25 to 400 g/ton of monensin (90% DM basis).
For the prevention and control of coccidiosis: Feed at a rate to provide 0.14 to 0.42 mg/lb of body weight/d of monensin up to a maximum of 200 mg/hd/d. The Type C medicated feed must contain 25 to 400 g/ton of monensin (90% DM basis).
Free-choice supplements: Approved supplements must provide not less than 50 nor more than 200 mg/hd/d of monensin.
Rumensin: Mature reproducing beef cows
For improved feed efficiency when receiving supplemental feed: Feed continuously at a rate of 50 to 200 mg/hd/d of monensin. Cows on pasture or in drylot must receive a minimum of 1.0lb of Type C medicated feed/hd/d. Do not self-feed.
For the prevention and control of coccidiosis: Feed at a rate of 0.14 to 0.42 mg/lb of body weight/d of monensin up to a maximum of 200 mg/hd/d.
For use in the treatment of bovine respiratory complex (shipping fever, pneumonia) usually associated with Pasteurella multocida and Arcanobacterium pyogenes; foot rot (necrotic pododermatitis) and calf diphtheria caused by Fusobacterium necrophorum and metritis caused by Arcanobacterium pyogenes. Inject intramuscularly 8 mg/lb one time daily. Treatment should be continued 24 hours following remission of disease signs, not to exceed 5 days. Do not inject more than 10 mL per site.
For the control of Bovine Respiratory Disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group: Feed continuously for a single, 14-day period at 568 to 757 g/ton of tilmicosin (100% DM basis) in a Type C medicated feed as the sole ration to provide 12.5 mg/kg of body weight/day.
Administer one dose in the ear subcutaneously according to label directions.
Precautions: Do not use Titanium BRSV 3, Titanium 3 LP, Titanium 3, Titanium IBR LP and Titanium IBR in pregnant cows or in calves nursing pregnant cows. Abortions may result.